Liu Xiaolong, Huang Zhihua, Luo Shaohua, Yang Shifang, Huang Junwei, Chen Pingping, Lin Qi, Wu Jian
Second Department of Geriatrics Respiratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial Geriatrics Institute, Guangzhou, China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Ann Transl Med. 2022 May;10(10):615. doi: 10.21037/atm-22-2130.
() empyema complicated with bronchopleural fistula (BPF) remains a significant challenge in diagnosis and treatment and the clinical outcomes are often unsatisfactory, especially in elderly patients. There is a paucity data related to the management of the condition. This is the first well-documented report of the therapeutic experience with bronchoscopic closure of a bronchopleural fistula with empyema related to infection in the elderly patients.
An 86-year-old non-smoking male with a history of diabetes mellitus, emphysema, and bronchiectasis, and a 72-year-old non-smoking male with two past surgeries for lung cancer, both presented with chronic fever, purulent expectoration, hemoptysis, and dyspnea, and were diagnosed with bronchopleural fistula associated with infection. Long-term antibiotic regimens, prolonged thoracic drainage, and endoscopic closure with biological glue were all unsuccessful. The culprit bronchus was identified precisely with the combined assistance of the instillation of methylene blue and the Chartis digital air leak monitoring system. Bronchoscopic interventional therapy was successfully performed using the Zephyr one-way endobronchial valve or the Amplatzer patent ductus arteriosus occluder. Finally, two patients succeeded in removing chest tube, and were able to conduct daily activities.
The successful bronchoscopic closure with the combined assistance of methylene blue and the Chartis digital air leak monitoring system provided valuable experience and novel strategy in dealing with BPF related to in the elderly and high-risk inoperable patients.
脓胸合并支气管胸膜瘘(BPF)在诊断和治疗方面仍然是一项重大挑战,临床结果往往不尽人意,尤其是在老年患者中。关于该病症管理的数据匮乏。这是第一份有充分记录的关于老年患者感染相关脓胸合并支气管胸膜瘘经支气管镜封堵治疗经验的报告。
一名86岁有糖尿病、肺气肿和支气管扩张病史的非吸烟男性,以及一名有两次肺癌手术史的72岁非吸烟男性,均出现慢性发热、脓性咳痰、咯血和呼吸困难,被诊断为与感染相关的支气管胸膜瘘。长期抗生素治疗方案、延长胸腔引流以及用生物胶进行内镜封堵均未成功。在亚甲蓝注入和Chartis数字漏气监测系统的联合辅助下,精确识别出罪魁祸首支气管。使用Zephyr单向支气管内瓣膜或Amplatzer动脉导管未闭封堵器成功进行了支气管镜介入治疗。最后,两名患者成功拔除胸管,并能够进行日常活动。
在亚甲蓝和Chartis数字漏气监测系统的联合辅助下成功进行支气管镜封堵,为处理老年及高危不可手术患者中与感染相关的支气管胸膜瘘提供了宝贵经验和新策略。